Regulus Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Regulus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Regulus Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regulus Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $124k | 79k | 1.57 |
| 2024-06-30 | $48k | 27k | 1.79 |
| 2024-03-31 | $57k | 20k | 2.88 |
| 2023-12-31 | $37 | 29 | 1.28 |
| 2023-09-30 | $28 | 20 | 1.40 |